Alkermes (ALKS) Other Non Operating Income (2010 - 2026)

Alkermes' (ALKS) quarterly Other Non Operating Income came in at -$1.3 million in Q1 2026, down 183.1% year-on-year from $1.6 million in Q1 2025, and down 130.31% on a QoQ basis from $4.3 million in Q4 2025.

Alkermes (ALKS) Other Non Operating Income (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Other Non Operating Income data on file, last reported at -$1.3 million in Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 183.1% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 62.3% decrease from a year earlier, with the FY2025 full-year figure at $6.3 million, down 19.22% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at -$1.3 million, down from $4.3 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for ALKS reached as high as $5.4 million in Q4 2023 and fell as low as -$1.9 million in Q3 2022.
  • Historically, Other Non Operating Income has averaged $1.1 million across 5 years, with a median of $558000.0 in 2024.
  • On a YoY basis, Other Non Operating Income climbed as much as 915.32% in 2022 and fell as far as 746.18% in 2022.
  • Year by year, Other Non Operating Income stood at -$1.9 million in 2022, then jumped by 388.92% to $5.4 million in 2023, then slipped by 6.5% to $5.0 million in 2024, then declined by 15.05% to $4.3 million in 2025, then plunged by 130.31% to -$1.3 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$1.3 million in Q1 2026, $4.3 million in Q4 2025, and -$280000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Alkermes 8.78 Bn 8.27 Bn 331.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.29 Mn
Dec 31, 2025 4.27 Mn
Sep 30, 2025 -280,000.00
Jun 30, 2025 771,000.00
Mar 31, 2025 1.56 Mn
Dec 31, 2024 5.02 Mn
Sep 30, 2024 558,000.00
Jun 30, 2024 2.05 Mn
Mar 31, 2024 182,000.00
Dec 31, 2023 5.37 Mn
Sep 30, 2023 149,000.00
Jun 30, 2023 -525,000.00
Mar 31, 2023 -39,000.00
Dec 31, 2022 -1.86 Mn
Sep 30, 2022 -1.86 Mn
Jun 30, 2022 1.81 Mn
Mar 31, 2022 2.43 Mn
Dec 31, 2021 3.20 Mn
Sep 30, 2021 288,000.00
Jun 30, 2021 -222,000.00